Page 128 - IJB-9-5
P. 128

International Journal of Bioprinting                               DLP-printed scaffold for bone regeneration


















































            Figure 5. Capacity for chondrogenic differentiation of BMSCs. (A) Fluorescent staining of Col-II and ACAN after 5 days of co-culture with scaffolds.
            (B, C) Protein expression of SOX9, Col-II, and ACAN in BMSCs using Western blot. (D) Gene expression of SOX9, Col-II, and ACAN in BMSCs using
            quantitative real-time PCR. Data were analyzed via one-way ANOVA and are shown as mean ± standard deviation (*p < 0.05, **p < 0.01, ***p < 0.001, n = 3).

            3.5. Capacity for migration and vascular           where an increase in CD31  of the GelMA/3%PMAA
            regeneration of HUVECs                             scaffold and an abundance of blood vessels within the
            The growth of blood vessels in the ECO process is essential   new bone tissue were found after 1 month (Figure 8). This
            for the mineralization of cartilage templates. Therefore,   indicated  that  the  GelMA/3%PMAA  scaffold  promoted
            we investigated the ability of GelMA/3%PMAA hydrogel   vascular regeneration at the defect site that was important
            to promote the migration of HUVECs and the formation   for the mineralization of cartilage templates during ECO.
            of blood vessels. As shown in Figure 6A–D, both transwell
            and scratch experiments were performed to investigate   3.6. Initiation of ECO in vivo
            that the addition of PMAA resulted in better migration   To verify the  early results of different scaffolds for the
            of HUVECs. Moreover,  in vitro tube formation assays   treatment of bone defects, we implanted them in rabbit
            also indicated that at 6 h, HUVECs could form more   femoral condylar defects and analyzed them using micro-CT,
            meshes in the presence of PMAA, with longer total length   which revealed that at week 4 and week 8, GelMA/3%PMAA
            (Figure 6E and F). To investigate the reason, we analyzed   scaffolds achieved better efficacy compared to other groups
            the expression of vascular-related factors by co-culturing   in both BMD, BV/TV, Th.Tb, and Th.Sp (Figure 7). We then
            HUVECs with hydrogel. GelMA/3%PMAA hydrogel was    analyzed the vascular regeneration at the defect site at week
            found to promote the protein and mRNA expression of   4 and found increased CD31 in GelMA/3%PMAA scaffolds
            VEGF (Figure 6G and H). The scaffold was then implanted   as well as abundant vascularity within the new bone tissue,
            into the defect site of the rabbit femoral condyle bone,   while no significant new bone was present around the GelMA


            Volume 9 Issue 5 (2023)                        120                         https://doi.org/10.18063/ijb.754
   123   124   125   126   127   128   129   130   131   132   133